Home > Press > Agilent opens custom optics shop to public
New offering is expected to service customers in electronic measurement and bio-analytical measurement
Agilent opens custom optics shop to public, capabilities help speed development of nanotechnology tools
Posted on April 27, 2006
Nanotechnology, with its potential to dramatically transform industries across the electronics, communications and life sciences sectors, is expected to usher in the next technology revolution. The quality and availability of custom precision optics and assemblies, both critical components in many tools used for nanotechnology research and development, is invaluable in the development and speed to market of nanotechnology applications. To facilitate that development, Agilent is opening its precision optics design and manufacturing capability, which has been in use for more than 35 years as an internal resource to external customers.
Agilent developed the ability to produce high-precision optical components and opto-mechanical assemblies at competitive costs to support its demanding laser interferometer business. This business provides very precise position or distance information for dimensional measurements or motion control applications. With the growing interest in nanotechnology, a number of customers approached Agilent for solutions to their unique optical needs. In response to these requests, Agilent is opening its internal optics capabilities to provide external customers precision components, optomechanical assemblies and customer design and manufacturing services.
Unlike optical design laboratories that outsource manufacturing, Agilent offers comprehensive and fully integrated services from initial concept through volume production for even the most complex assemblies. This enables Agilent to optimize across the delivery chain to lower costs, improve performance and simplify procedures. The result is faster turnaround, clear accountability at every step, and all the benefits of decades of process-driven, real-world manufacturing experience.
This new offering from Agilent is expected to service customers that cross the company's two chief areas of business -- electronic measurement and bio-analytical measurement -- both of which have nanotechnology application customers.
See the originl release
for more information.
About Agilent Technologies:
Agilent Technologies is the world's premier measurement company. Agilent provides core electronic and bio-analytical measurement tools to advance the electronics, communications, life science research, environmental and petrochemical industries.
About two-thirds of Agilent's revenue was generated from outside of the United States in fiscal 2005. With 20,000 employees, our global presence offers a competitive advantage. Agilent's manufacturing, R&D, sales and support capabilities around the world give customers the flexibility they need in today's competitive environment.
For more information, please click here.
+1 970 679 5397
Copyright © Agilent Technologies
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
NanoTechnology for Defense (NT4D) October 22nd, 2014
Mechanism behind nature's sparkles revealed October 22nd, 2014
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014
NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014
Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014
Super stable garnet ceramics may be ideal for high-energy lithium batteries October 21st, 2014
Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014